BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 9003537)

  • 1. Reduced expression of mature TGF beta 1 correlates with the suppression of rat hepatocyte apoptosis by the peroxisome proliferator, nafenopin.
    Strange J; Roberts RA
    Mutat Res; 1996 Nov; 372(1):107-13. PubMed ID: 9003537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role for tumor necrosis factor alpha receptor 1 and interleukin-1 receptor in the suppression of mouse hepatocyte apoptosis by the peroxisome proliferator nafenopin.
    West DA; James NH; Cosulich SC; Holden PR; Brindle R; Rolfe M; Roberts RA
    Hepatology; 1999 Dec; 30(6):1417-24. PubMed ID: 10573520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Species differences in response to peroxisome proliferators correlate in vitro with induction of DNA synthesis rather than suppression of apoptosis.
    James NH; Roberts RA
    Carcinogenesis; 1996 Aug; 17(8):1623-32. PubMed ID: 8761418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour necrosis factor alpha (TNFalpha): role in suppression of apoptosis by the peroxisome proliferator nafenopin.
    Holden PR; Hasmall SC; James NH; West DR; Brindle RD; Gonzalez FJ; Peters JM; Roberts RA
    Cell Mol Biol (Noisy-le-grand); 2000 Feb; 46(1):29-39. PubMed ID: 10726969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of various peroxisome proliferators on peroxisomal enzyme activities, DNA synthesis, and apoptosis in rat and human hepatocyte cultures.
    Goll V; Alexandre E; Viollon-Abadie C; Nicod L; Jaeck D; Richert L
    Toxicol Appl Pharmacol; 1999 Oct; 160(1):21-32. PubMed ID: 10502499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The peroxisome proliferator class of non-genotoxic hepatocarcinogens synergize with epidermal growth factor to promote clonal expansion of initiated rat hepatocytes.
    James NH; Roberts RA
    Carcinogenesis; 1994 Dec; 15(12):2687-94. PubMed ID: 8001222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of rodent hepatocarcinogenic peroxisome proliferators on fatty acyl-CoA oxidase, DNA synthesis, and apoptosis in cultured human and rat hepatocytes.
    Perrone CE; Shao L; Williams GM
    Toxicol Appl Pharmacol; 1998 Jun; 150(2):277-86. PubMed ID: 9653058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of liver cell apoptosis in vitro by the non-genotoxic hepatocarcinogen and peroxisome proliferator nafenopin.
    Bayly AC; Roberts RA; Dive C
    J Cell Biol; 1994 Apr; 125(1):197-203. PubMed ID: 8138571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The non-genotoxic hepatocarcinogen nafenopin suppresses rodent hepatocyte apoptosis induced by TGFbeta1, DNA damage and Fas.
    Gill JH; James NH; Roberts RA; Dive C
    Carcinogenesis; 1998 Feb; 19(2):299-304. PubMed ID: 9498280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of hepatic non-parenchymal cells in the response of rat hepatocytes to the peroxisome proliferator nafenopin in vitro.
    Hasmall SC; West DA; Olsen K; Roberts RA
    Carcinogenesis; 2000 Dec; 21(12):2159-65. PubMed ID: 11133804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of apoptosis in mouse hepatocytes and alteration of apoptosis by nongenotoxic carcinogens.
    Christensen JG; Gonzales AJ; Cattley RC; Goldsworthy TL
    Cell Growth Differ; 1998 Sep; 9(9):815-25. PubMed ID: 9751125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor beta 1 increases the number of apoptotic bodies and decreases intracellular pH in isolated periportal and perivenular rat hepatocytes.
    Benedetti A; Di Sario A; Svegliati Baroni G; Jezequel AM
    Hepatology; 1995 Nov; 22(5):1488-98. PubMed ID: 7590668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The rodent non-genotoxic hepatocarcinogen nafenopin suppresses apoptosis preferentially in non-cycling hepatocytes but also elevates CDK4, a cell cycle progression factor.
    Gill JH; Brickell P; Dive C; Roberts RA
    Carcinogenesis; 1998 Oct; 19(10):1743-7. PubMed ID: 9806153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The peroxisome proliferator nafenopin does not suppress hepatocyte apoptosis in guinea-pig liver in vivo nor in human hepatocytes in vitro.
    Hasmall SC; James NH; Soames AR; Roberts RA
    Arch Toxicol; 1998 Dec; 72(12):777-83. PubMed ID: 9950074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of TGF-beta-induced apoptosis in primary cultures of hepatocytes by calpain inhibitors.
    Gressner AM; Lahme B; Roth S
    Biochem Biophys Res Commun; 1997 Feb; 231(2):457-62. PubMed ID: 9070300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse hepatocyte response to peroxisome proliferators: dependency on hepatic nonparenchymal cells and peroxisome proliferator activated receptor alpha (PPARalpha).
    Hasmall S; James N; Hedley K; Olsen K; Roberts R
    Arch Toxicol; 2001 Aug; 75(6):357-61. PubMed ID: 11570693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour necrosis factor alpha (TNF alpha) suppresses apoptosis and induces DNA synthesis in rodent hepatocytes: a mediator of the hepatocarcinogenicity of peroxisome proliferators?
    Rolfe M; James NH; Roberts RA
    Carcinogenesis; 1997 Nov; 18(11):2277-80. PubMed ID: 9395232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The rodent nongenotoxic hepatocarcinogen and peroxisome proliferator nafenopin inhibits intercellular communication in rat but not guinea-pig hepatocytes, perturbing S-phase but not apoptosis.
    Elcock FJ; Chipman JK; Roberts RA
    Arch Toxicol; 1998 Jun; 72(7):439-44. PubMed ID: 9708883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulation of apoptosis by c-myc in transgenic hepatocytes and effects of growth factors and nongenotoxic carcinogens.
    Christensen JG; Goldsworthy TL; Cattley RC
    Mol Carcinog; 1999 Aug; 25(4):273-84. PubMed ID: 10449034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of mitotic inhibition in corneal endothelium: contact inhibition and TGF-beta2.
    Joyce NC; Harris DL; Mello DM
    Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2152-9. PubMed ID: 12091410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.